Loading…

Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation

The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a seri...

Full description

Saved in:
Bibliographic Details
Published in:Inorganic chemistry 2015-01, Vol.54 (2), p.470-475
Main Authors: Yellol, Gorakh S, Yellol, Jyoti G, Kenche, Vijaya B, Liu, Xiang Ming, Barnham, Kevin J, Donaire, Antonio, Janiak, Christoph, Ruiz, José
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3
cites cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3
container_end_page 475
container_issue 2
container_start_page 470
container_title Inorganic chemistry
container_volume 54
creator Yellol, Gorakh S
Yellol, Jyoti G
Kenche, Vijaya B
Liu, Xiang Ming
Barnham, Kevin J
Donaire, Antonio
Janiak, Christoph
Ruiz, José
description The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.
doi_str_mv 10.1021/ic502119b
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1872828735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793260447</sourcerecordid><originalsourceid>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</originalsourceid><addsrcrecordid>eNqFkU9u1DAUxi0EokNhwQWQN0itRIodO_-Wo1Ghkaq2oiCxi-z4ZeoqsQc7rpquuAJX6ZozcAhOgmdSukJi9fk9_973ZH8IvabkiJKUvtdtFoVW8gla0CwlSUbJ16doQUg80zyv9tAL768JIRXj-XO0l2acVLxKF-jn5WTGK_DaY9vh9Pf3HxeT02rqEwnmTg9aiTvbA65jU4fhoK7rw3f4U4gzZq5jKYzCF70YtZk7eGWHTQ-34I_w5RjUtPWOE3jZjvpGjxMWHtfmSks9WrfbvBym3moV9_-6x8v12sE6-lmz8z6D4Oxob3W7nT2-EX3YXb5EzzrRe3j1oPvoy4fjz6uT5PT8Y71aniaClXRMhIwvT2XHgEgGmZC0lDKHqHmnhOSsK8u85G0rScY7lREmBe-IKNqS5QqA7aOD2Xfj7LcAfmwG7Vvoe2HABt_QskjLtCxY9n-0qFiaE86LiB7OaOus9w66ZuP0INzUUNJsc20ec43smwfbIAdQj-TfICPwdgZE65trG5yJH_IPoz9kt677</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793260447</pqid></control><display><type>article</type><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</creator><creatorcontrib>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</creatorcontrib><description>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</description><identifier>ISSN: 0020-1669</identifier><identifier>EISSN: 1520-510X</identifier><identifier>DOI: 10.1021/ic502119b</identifier><identifier>PMID: 25409492</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Agglomeration ; Amyloid beta-Peptides - chemistry ; Amyloid beta-Peptides - toxicity ; Animals ; Benzimidazoles - chemistry ; Cationic ; Chemistry Techniques, Synthetic ; Design analysis ; Diffraction ; Drug Design ; Female ; Fluorescence ; Iridium - chemistry ; Ligands ; Mice ; Models, Molecular ; Molecular Conformation ; Neurons - cytology ; Neurons - drug effects ; Organometallic Compounds - chemical synthesis ; Organometallic Compounds - chemistry ; Organometallic Compounds - pharmacology ; Peptide Fragments - chemistry ; Peptide Fragments - toxicity ; Platinum - chemistry ; Pregnancy ; Protein Multimerization - drug effects ; Protein Structure, Secondary ; Ruthenium - chemistry ; Synthesis ; Toxicity ; Unit cell</subject><ispartof>Inorganic chemistry, 2015-01, Vol.54 (2), p.470-475</ispartof><rights>Copyright © 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</citedby><cites>FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25409492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yellol, Gorakh S</creatorcontrib><creatorcontrib>Yellol, Jyoti G</creatorcontrib><creatorcontrib>Kenche, Vijaya B</creatorcontrib><creatorcontrib>Liu, Xiang Ming</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Donaire, Antonio</creatorcontrib><creatorcontrib>Janiak, Christoph</creatorcontrib><creatorcontrib>Ruiz, José</creatorcontrib><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><title>Inorganic chemistry</title><addtitle>Inorg. Chem</addtitle><description>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</description><subject>Agglomeration</subject><subject>Amyloid beta-Peptides - chemistry</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Animals</subject><subject>Benzimidazoles - chemistry</subject><subject>Cationic</subject><subject>Chemistry Techniques, Synthetic</subject><subject>Design analysis</subject><subject>Diffraction</subject><subject>Drug Design</subject><subject>Female</subject><subject>Fluorescence</subject><subject>Iridium - chemistry</subject><subject>Ligands</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>Organometallic Compounds - chemical synthesis</subject><subject>Organometallic Compounds - chemistry</subject><subject>Organometallic Compounds - pharmacology</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - toxicity</subject><subject>Platinum - chemistry</subject><subject>Pregnancy</subject><subject>Protein Multimerization - drug effects</subject><subject>Protein Structure, Secondary</subject><subject>Ruthenium - chemistry</subject><subject>Synthesis</subject><subject>Toxicity</subject><subject>Unit cell</subject><issn>0020-1669</issn><issn>1520-510X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkU9u1DAUxi0EokNhwQWQN0itRIodO_-Wo1Ghkaq2oiCxi-z4ZeoqsQc7rpquuAJX6ZozcAhOgmdSukJi9fk9_973ZH8IvabkiJKUvtdtFoVW8gla0CwlSUbJ16doQUg80zyv9tAL768JIRXj-XO0l2acVLxKF-jn5WTGK_DaY9vh9Pf3HxeT02rqEwnmTg9aiTvbA65jU4fhoK7rw3f4U4gzZq5jKYzCF70YtZk7eGWHTQ-34I_w5RjUtPWOE3jZjvpGjxMWHtfmSks9WrfbvBym3moV9_-6x8v12sE6-lmz8z6D4Oxob3W7nT2-EX3YXb5EzzrRe3j1oPvoy4fjz6uT5PT8Y71aniaClXRMhIwvT2XHgEgGmZC0lDKHqHmnhOSsK8u85G0rScY7lREmBe-IKNqS5QqA7aOD2Xfj7LcAfmwG7Vvoe2HABt_QskjLtCxY9n-0qFiaE86LiB7OaOus9w66ZuP0INzUUNJsc20ec43smwfbIAdQj-TfICPwdgZE65trG5yJH_IPoz9kt677</recordid><startdate>20150120</startdate><enddate>20150120</enddate><creator>Yellol, Gorakh S</creator><creator>Yellol, Jyoti G</creator><creator>Kenche, Vijaya B</creator><creator>Liu, Xiang Ming</creator><creator>Barnham, Kevin J</creator><creator>Donaire, Antonio</creator><creator>Janiak, Christoph</creator><creator>Ruiz, José</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7TK</scope></search><sort><creationdate>20150120</creationdate><title>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</title><author>Yellol, Gorakh S ; Yellol, Jyoti G ; Kenche, Vijaya B ; Liu, Xiang Ming ; Barnham, Kevin J ; Donaire, Antonio ; Janiak, Christoph ; Ruiz, José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Agglomeration</topic><topic>Amyloid beta-Peptides - chemistry</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Animals</topic><topic>Benzimidazoles - chemistry</topic><topic>Cationic</topic><topic>Chemistry Techniques, Synthetic</topic><topic>Design analysis</topic><topic>Diffraction</topic><topic>Drug Design</topic><topic>Female</topic><topic>Fluorescence</topic><topic>Iridium - chemistry</topic><topic>Ligands</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>Organometallic Compounds - chemical synthesis</topic><topic>Organometallic Compounds - chemistry</topic><topic>Organometallic Compounds - pharmacology</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - toxicity</topic><topic>Platinum - chemistry</topic><topic>Pregnancy</topic><topic>Protein Multimerization - drug effects</topic><topic>Protein Structure, Secondary</topic><topic>Ruthenium - chemistry</topic><topic>Synthesis</topic><topic>Toxicity</topic><topic>Unit cell</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yellol, Gorakh S</creatorcontrib><creatorcontrib>Yellol, Jyoti G</creatorcontrib><creatorcontrib>Kenche, Vijaya B</creatorcontrib><creatorcontrib>Liu, Xiang Ming</creatorcontrib><creatorcontrib>Barnham, Kevin J</creatorcontrib><creatorcontrib>Donaire, Antonio</creatorcontrib><creatorcontrib>Janiak, Christoph</creatorcontrib><creatorcontrib>Ruiz, José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Neurosciences Abstracts</collection><jtitle>Inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yellol, Gorakh S</au><au>Yellol, Jyoti G</au><au>Kenche, Vijaya B</au><au>Liu, Xiang Ming</au><au>Barnham, Kevin J</au><au>Donaire, Antonio</au><au>Janiak, Christoph</au><au>Ruiz, José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation</atitle><jtitle>Inorganic chemistry</jtitle><addtitle>Inorg. Chem</addtitle><date>2015-01-20</date><risdate>2015</risdate><volume>54</volume><issue>2</issue><spage>470</spage><epage>475</epage><pages>470-475</pages><issn>0020-1669</issn><eissn>1520-510X</eissn><abstract>The design of small molecules that can target the aggregation of Aβ as potential therapeutic agents for Alzheimer’s disease is an area of study that has attracted a lot of attention recently. The novel ligand methyl 1-butyl-2-pyridyl-benzimidazole carboxylate was prepared for the synthesis of a series of new iridium(III), ruthenium(II), and platinum(II) 2-pyridyl-benzimidazole complexes. The crystal structure of the half-sandwich iridium(III) complex was established by X-ray diffraction. An arrangement of two cationic complexes in the unit cell is observed, and it seems to be organized by weak π···π interactions that are taking place between two symmetry-related benzimidazole ring systems. All new compounds inhibited aggregation of Aβ1–42 in vitro as shown by both thioflavin T fluorescence assay and transmission electron microscopy. Among them the Ir compound rescued the toxicity of Aβ1–42 in primary cortical neurons effectively.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>25409492</pmid><doi>10.1021/ic502119b</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-1669
ispartof Inorganic chemistry, 2015-01, Vol.54 (2), p.470-475
issn 0020-1669
1520-510X
language eng
recordid cdi_proquest_miscellaneous_1872828735
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Agglomeration
Amyloid beta-Peptides - chemistry
Amyloid beta-Peptides - toxicity
Animals
Benzimidazoles - chemistry
Cationic
Chemistry Techniques, Synthetic
Design analysis
Diffraction
Drug Design
Female
Fluorescence
Iridium - chemistry
Ligands
Mice
Models, Molecular
Molecular Conformation
Neurons - cytology
Neurons - drug effects
Organometallic Compounds - chemical synthesis
Organometallic Compounds - chemistry
Organometallic Compounds - pharmacology
Peptide Fragments - chemistry
Peptide Fragments - toxicity
Platinum - chemistry
Pregnancy
Protein Multimerization - drug effects
Protein Structure, Secondary
Ruthenium - chemistry
Synthesis
Toxicity
Unit cell
title Synthesis of 2‑Pyridyl-benzimidazole Iridium(III), Ruthenium(II), and Platinum(II) Complexes. Study of the Activity as Inhibitors of Amyloid‑β Aggregation and Neurotoxicity Evaluation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A42%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%202%E2%80%91Pyridyl-benzimidazole%20Iridium(III),%20Ruthenium(II),%20and%20Platinum(II)%20Complexes.%20Study%20of%20the%20Activity%20as%20Inhibitors%20of%20Amyloid%E2%80%91%CE%B2%20Aggregation%20and%20Neurotoxicity%20Evaluation&rft.jtitle=Inorganic%20chemistry&rft.au=Yellol,%20Gorakh%20S&rft.date=2015-01-20&rft.volume=54&rft.issue=2&rft.spage=470&rft.epage=475&rft.pages=470-475&rft.issn=0020-1669&rft.eissn=1520-510X&rft_id=info:doi/10.1021/ic502119b&rft_dat=%3Cproquest_cross%3E1793260447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a381t-ab0002bf3e0b3e5ab18bb6eab16fdab43f88684ccb054fd503ba4f0a7c836dee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1793260447&rft_id=info:pmid/25409492&rfr_iscdi=true